PGI2 enhanced cAMP content in bovine coronary arteries in the presence of isobutylmethylxanthine
- PMID: 91976
- DOI: 10.1007/BF00499051
PGI2 enhanced cAMP content in bovine coronary arteries in the presence of isobutylmethylxanthine
Abstract
Incubation of bovine coronary artery (BCA) rings with isobutylmethylxanthine (IBMX) resulted in a time-dependent increase of cAMP content. This effect was blocked, when the rings were preincubated with indomethacine or 15-hydroperoxy-arachidonic acid for 5 min, indicating that the IBMX-induced increase in cAMP content may depend on endogenous PGI2 formation. PGE2 did not increase the cAMP content in BCA rings. Dipyridamole did not effect cAMP content, when used as a substitute for IBMX. It is suggested that PGI2 stimulates cAMP formation in arterial walls, but that this effect only becomes visible in the presence of a phosphodiesterase inhibitor.
Similar articles
-
Effects of PGI2 and PGI analogues on cAMP levels in cultured endothelial and smooth muscle cells derived from bovine arteries.Naunyn Schmiedebergs Arch Pharmacol. 1980 Feb;311(1):67-70. doi: 10.1007/BF00500304. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 6154247
-
Prostacyclin stimulation of dog arterial cyclic AMP levels.Prostaglandins. 1979 Dec;18(6):915-25. doi: 10.1016/0090-6980(79)90128-x. Prostaglandins. 1979. PMID: 232764
-
Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries.Naunyn Schmiedebergs Arch Pharmacol. 1979 Jan;306(1):101-3. doi: 10.1007/BF00515602. Naunyn Schmiedebergs Arch Pharmacol. 1979. PMID: 218118
-
Mode of action of coronary arterial relaxation by prostacyclin.J Cyclic Nucleotide Res. 1980;6(6):451-60. J Cyclic Nucleotide Res. 1980. PMID: 6163806
-
Arachidonic acid metabolism in cultured aortic endothelial cells. Effect of cAMP and 3-isobutyl-1-methylxanthine.Biochem Pharmacol. 1985 Jan 1;34(1):119-23. doi: 10.1016/0006-2952(85)90109-1. Biochem Pharmacol. 1985. PMID: 2578280
Cited by
-
Effects of dipyridamole in vivo on ATP and cAMP content in platelets and arterial walls and on atherosclerotic plaque formation.Naunyn Schmiedebergs Arch Pharmacol. 1979 Oct;309(1):59-64. doi: 10.1007/BF00498756. Naunyn Schmiedebergs Arch Pharmacol. 1979. PMID: 230417
-
Responses of human, monkey and dog coronary arteries in vitro to carbocyclic thromboxane A2 and vasodilators.Br J Pharmacol. 1984 Oct;83(2):399-408. doi: 10.1111/j.1476-5381.1984.tb16500.x. Br J Pharmacol. 1984. PMID: 6435709 Free PMC article.
-
Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells.Br J Pharmacol. 1989 May;97(1):51-6. doi: 10.1111/j.1476-5381.1989.tb11922.x. Br J Pharmacol. 1989. PMID: 2541859 Free PMC article.
-
Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells.Br J Pharmacol. 1988 Jan;93(1):229-39. doi: 10.1111/j.1476-5381.1988.tb11426.x. Br J Pharmacol. 1988. PMID: 2894877 Free PMC article.
-
Endothelium-mediated coronary dilatation by adenosine does not depend on endothelial adenylate cyclase activation: studies in isolated guinea pig hearts.Pflugers Arch. 1988 Nov;413(1):1-7. doi: 10.1007/BF00581221. Pflugers Arch. 1988. PMID: 2464158